BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15837136)

  • 1. Co-localization and distribution of corticotrophin-releasing hormone, arginine vasopressin and enkephalin in the paraventricular nucleus of sheep: a sex comparison.
    Rivalland ET; Iqbal J; Clarke IJ; Turner AI; Tilbrook AJ
    Neuroscience; 2005; 132(3):755-66. PubMed ID: 15837136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and restraint stress results in differential activation of corticotrophin-releasing hormone and arginine vasopressin neurons in sheep.
    Rivalland ET; Clarke IJ; Turner AI; Pompolo S; Tilbrook AJ
    Neuroscience; 2007 Mar; 145(3):1048-58. PubMed ID: 17289277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
    Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distributions of pro-vasopressin expressing and pro-vasopressin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalectomized rats.
    Whitnall MH
    J Comp Neurol; 1988 Sep; 275(1):13-28. PubMed ID: 3262632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projections to the preoptic area from the paraventricular nucleus, arcuate nucleus and the bed nucleus of the stria terminalis are unlikely to be involved in stress-induced suppression of GnRH secretion in sheep.
    Rivalland ET; Tilbrook AJ; Turner AI; Iqbal J; Pompolo S; Clarke IJ
    Neuroendocrinology; 2006; 84(1):1-13. PubMed ID: 17047317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical detection of cholecystokinin and corticotrophin-releasing hormone neuropeptides in the hypothalamic paraventricular nucleus of the jerboa (Jaculus orientalis): modulation by immobilisation stress.
    Barakat Y; Pape JR; Boutahricht M; El Ouezzani S; Alaoui A; Chaigniau M; Tramu G; Magoul R
    J Neuroendocrinol; 2006 Oct; 18(10):767-75. PubMed ID: 16965295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender difference in age-related number of corticotropin-releasing hormone-expressing neurons in the human hypothalamic paraventricular nucleus and the role of sex hormones.
    Bao AM; Swaab DF
    Neuroendocrinology; 2007; 85(1):27-36. PubMed ID: 17308368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of corticotropin-releasing factor and enkephalin in the paraventricular nucleus of the rat.
    Pretel S; Piekut D
    J Comp Neurol; 1990 Apr; 294(2):192-201. PubMed ID: 2332527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus.
    Bao AM; Swaab DF
    Vitam Horm; 2010; 82():339-65. PubMed ID: 20472147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stress system in depression and neurodegeneration: focus on the human hypothalamus.
    Bao AM; Meynen G; Swaab DF
    Brain Res Rev; 2008 Mar; 57(2):531-53. PubMed ID: 17524488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central administration of cocaine- and amphetamine-regulated transcript increases phosphorylation of cAMP response element binding protein in corticotropin-releasing hormone-producing neurons but not in prothyrotropin-releasing hormone-producing neurons in the hypothalamic paraventricular nucleus.
    Sarkar S; Wittmann G; Fekete C; Lechan RM
    Brain Res; 2004 Mar; 999(2):181-92. PubMed ID: 14759497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 gene knockout influences energy balance regulating peptides in the hypothalamic paraventricular and supraoptic nuclei.
    Benrick A; Schéle E; Pinnock SB; Wernstedt-Asterholm I; Dickson SL; Karlsson-Lindahl L; Jansson JO
    J Neuroendocrinol; 2009 Jul; 21(7):620-8. PubMed ID: 19490366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin-containing neurons of the hypothalamic parvocellular paraventricular nucleus of the jerboa: plasticity related to immobilization stress.
    Barakat Y; Pape JR; Boutahricht M; El Ouezzani S; Alaoui A; Chaigniau M; Barakat L; Tramu G; Mâgoul R
    Neuroendocrinology; 2006; 84(6):396-404. PubMed ID: 17384516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
    Maruyama H; Makino S; Noguchi T; Nishioka T; Hashimoto K
    Neuroendocrinology; 2007; 86(1):1-16. PubMed ID: 17551262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of repeated stressor exposure on the release of corticotropin-releasing hormone, arginine-vasopressin and bombesin-like peptides at the anterior pituitary.
    Merali Z; Hayley S; Kent P; McIntosh J; Bédard T; Anisman H
    Behav Brain Res; 2009 Mar; 198(1):105-12. PubMed ID: 19014976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine vasopressin is an important regulator in antinociceptive modulation of hypothalamic paraventricular nucleus in the rat.
    Yang J; Yang Y; Chen JM; Xu HT; Liu WY; Wang CH; Lin BC
    Neuropeptides; 2007 Jun; 41(3):165-76. PubMed ID: 17316791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders.
    Bao AM; Hestiantoro A; Van Someren EJ; Swaab DF; Zhou JN
    Brain; 2005 Jun; 128(Pt 6):1301-13. PubMed ID: 15705605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone.
    Wu YH; Zhou JN; Balesar R; Unmehopa U; Bao A; Jockers R; Van Heerikhuize J; Swaab DF
    J Comp Neurol; 2006 Dec; 499(6):897-910. PubMed ID: 17072839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen inhibits the increases in hypothalamic corticotropin-releasing hormone (CRH) and CRH-immunoreactivity following gonadectomy.
    Bingaman EW; Magnuson DJ; Gray TS; Handa RJ
    Neuroendocrinology; 1994 Mar; 59(3):228-34. PubMed ID: 8159272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.